Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes
Abstract Background Skin autofluorescence (SAF) is a non-invasive marker of tissue accumulation of advanced glycation endproducts (AGE). Recently, we demonstrated in the general population that elevated SAF levels predict the development of type 2 diabetes (T2D), cardiovascular disease (CVD) and mor...
Furkejuvvon:
| Váldodahkkit: | , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2021-01-01
|
| Ráidu: | BMC Endocrine Disorders |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s12902-020-00676-4 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
